HAVCR2 and rheumatoid arthritis: To assess TIM–3 expression in RA, we subjected fresh peripheral blood samples from HC and patients with RA to flow cytometry and found that TIM–3 is barely expressed on peripheral blood CD3(+) T cells or CD14(−) and CD16(+) neutrophils, both in HC and patients with RA (Figure 6).